FOLLOW US :
  • |
  • |

Equity

Daily Market Tracker
Market Analysis
Other Markets
Corporate Actions
News
Corporate Information

Prev Quarter Comp Home > Equity > Corporate Information > Prev Quarter Comp

Caplin Point Laboratories LtdIndustry : Pharmaceuticals - Indian - Formulations
BSE Code:524742 P/E (TTM) :35.65
ISIN Demat:INE475E01026 Div & Yield %:0.35 EPS (TTM) :47.66
Book Value (RS) :242.5445604 Market Cap (Rs Cr.):12913.25 Face Value (RS) :2
    Change Company 
Particulars Quarter Ended
(Dec 2025)		 Quarter Ended
(Dec 2024)		 Quarter Ended
(% Var)
Sales 189.22 185.23 2.15
Other Income 31.73 28.83 10.06
PBIDT 123.45 106.22 16.22
Interest 0.07 0.04 75.00
PBDT 123.38 106.18 16.20
Depreciation 6.37 6.01 5.99
PBT 117.01 100.17 16.81
Tax 29.35 25.55 14.87
Deferred Tax 0.38 -0.09 0.00
PAT 87.28 74.71 16.83

IMPORTANT LINKS

QUICK LINKS

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)